EMN Stock Analysis — Eastman Chemical Company
Sector: Chemicals
AI Verdict
EMN trades at 12.5x next year's earnings while analysts expect a huge 75.2% EPS jump — that's cheap for the growth on offer if their specialty chemicals moat keeps competitors at bay.
Competitive Moat
Eastman Chemical specializes in advanced materials and specialty additives, with a moat built on proprietary chemical processes and long-term supply agreements that create switching costs for industrial customers. Their portfolio includes patented polymers and sustainable materials that are difficult for competitors to replicate at scale.
Summary
EMN is notable for its sharp expected earnings rebound, with forward EPS growth forecast at 75.2%.
Where It Stands
EMN has delivered a 0.62% 1-year return, trades at 21.9x trailing P/E (below the sector's 22x median), and its RSI of 57.0 signals a neutral stance.
Key Metrics
- RSI: 57 — Neutral
- Trailing P/E: 21.9x
- Forward P/E: 12.5x
- PEG Ratio: 0.28
- Earnings Growth: +0.8%
- Revenue Growth: -0.1%
- Market Cap: $8.7B
- Dividend Yield: 0.04%
- 1-Year Return: 0.62%
- 52-Week High: $84.18
- 52-Week Low: $56.11
Analyst Consensus
13 Buy · 9 Hold · 0 Sell (22 analysts)
Bull Case
With a forward P/E of 12.5x and consensus EPS growth of 75.2%, EMN is priced cheaply for the growth analysts expect.
Bear Case
If the forward P/E rerates back to the trailing 21.9x, that would imply a 75% price jump is already being counted on, so any earnings miss could trigger a sharp pullback.
Catalyst to Watch
Watch for quarterly earnings — if the 75.2% EPS growth materializes, the low forward P/E could quickly rerate upward.